1-O-METHYL-2,3-O-ISOPROPYLIDENE-5-(4-PROPYL-1-H-1,2,3-TRIAZOL-1-YL)-BETA-D-RIBOFURANOSE
Compound with spectra: 1 NMR
| SpectraBase Compound ID | G7uULTzVN1L |
|---|---|
| InChI | InChI=1S/C14H23N3O4/c1-5-6-9-7-17(16-15-9)8-10-11-12(13(18-4)19-10)21-14(2,3)20-11/h7,10-13H,5-6,8H2,1-4H3/t10-,11-,12-,13-/m0/s1 |
| InChIKey | JMPBCGXDCFHBCG-CYDGBPFRSA-N |
| Mol Weight | 297.36 g/mol |
| Molecular Formula | C14H23N3O4 |
| Exact Mass | 297.168856 g/mol |
| Enantiomer InChIKey | JMPBCGXDCFHBCG-FDYHWXHSSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
METHYL-5-DEOXY-5-C-(4-HXDROXYMETHYL-1,2,3-TRIAZOL-1-YL)-2,3-O-ISOPROPYLIDENE-BETA-D-RIBOFUTANOSIDE
5-DEOXY-5-C-(4-ETHOXYCARBONYL-1,2,3-TRIAZOL-1-YL)-1,2-O-ISOPROPYLIDENE-ALPHA-D-XYLOFURANOSE
5-DEOXY-1,2-O-ISOPROPYLIDENE-5-C-(4-PHENYL-1,2,3-TRIAZOL-1-YL)-ALPHA-D-XYLOFURANOSE
Methyl 5-amino-5-deoxy-2,3-O-isopropylidene-5-methyl-A-D-talo-hexofuranoside
METHYL-2-(METHYL-2,3-O-ISOPROPYLIDEN-BETA-D-RIBO-1,4-FURANOSYL-CARBONYL)-(AMINOACETYL)-AMINOACETATE
.beta.-D-Galactopyranoside, methyl 6-bromo-6-deoxy-2-O-(1-methoxy-1-methylethyl)-3,4-O-(1-methylethylidene)-
Methyl 5,6-dideoxy-5-isocyanato-2,3-O-isopropylidene-5-C-methyl-B-L-ribo-hexofuranoside
METHYL-2,6-DI-O-BENZYL-3,4-O-ISOPROPYLIDENE-ALPHA-D-TALOPYRANOSIDE
1,5-Benzylidene-2,3-isopropylidene-.beta.,D-ribofuranose
METHYL-5-CYANO-6-DEOXY-2,3-O-ISOPROPYLIDENE-BETA-L-GULOFURANOSIDE
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis, Biological Activity, and Molecular Modeling Studies of 1H-1,2,3-Triazole Derivatives of Carbohydrates as α-Glucosidases Inhibitors | Journal of Medicinal Chemistry | 2010 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.